Since IL-33 can promote Th2 response and increase the production of type 2 cytokines, such as IL-4, IL-5, and IL-13, which leads to extracellular matrix accumulation, administration of recombinant IL-33 to mice exaggerated liver fibrosis in NASH mice (72). This evidence concerns the gene IL13 and metabolic dysfunction-associated steatohepatitis.